Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine for ischemic stroke
RBR-4r22qwnPhase 2Not yet recruiting
- Sponsor
- Universidade Federal de Sergipe
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Trimetazidine + standard treatment with Placebo + standard treatment (2 arms). Planned start May 2026; status: not yet recruiting.
02
Drugs
trimetazidine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on RBR-4r22qwn.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4r22qwn.